CD40 and CD154 in cell-mediated immunity - PubMed (original) (raw)
Review
CD40 and CD154 in cell-mediated immunity
I S Grewal et al. Annu Rev Immunol. 1998.
Abstract
CD40-CD154-mediated contact-dependent signals between B and T cells are required for the generation of thymus dependent (TD) humoral immune responses. CD40-CD154 interactions are however also important in many other cell systems. CD40 is expressed by a large variety of cell types other than B cells, and these include dendritic cells, follicular dendritic cells, monocytes, macrophages, mast cells, fibroblasts, and endothelial cells. CD40- and CD154-knockout mice and antibodies to CD40 and CD154 have helped to elucidate the role of the CD40-CD154 system in immune responses. Recently published studies indicate that CD40-CD154 interactions can influence T cell priming and T cell-mediated effector functions; they can also upregulate costimulatory molecules and activate macrophages, NK cells, and endothelia as well as participate in organ-specific autoimmune disease, graft rejection, and even atherosclerosis. This review focuses on the role of the CD40-CD154 system in the regulation of many newly discovered functions important in inflammation and cell-mediated immunity.
Similar articles
- Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM, Kerkvliet NI. Shepherd DM, et al. J Immunol. 1999 Sep 1;163(5):2470-7. J Immunol. 1999. PMID: 10452982 - Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.
Mackey MF, Gunn JR, Ting PP, Kikutani H, Dranoff G, Noelle RJ, Barth RJ Jr. Mackey MF, et al. Cancer Res. 1997 Jul 1;57(13):2569-74. Cancer Res. 1997. PMID: 9205055 - CD40/CD154 interactions at the interface of tolerance and immunity.
Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. Quezada SA, et al. Annu Rev Immunol. 2004;22:307-28. doi: 10.1146/annurev.immunol.22.012703.104533. Annu Rev Immunol. 2004. PMID: 15032580 Review. - The role of CD40-CD154 interaction in cell immunoregulation.
Xu Y, Song G. Xu Y, et al. J Biomed Sci. 2004 Jul-Aug;11(4):426-38. doi: 10.1007/BF02256091. J Biomed Sci. 2004. PMID: 15153777 Review.
Cited by
- Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters.
Park HB, Kim KH, Kim JH, Kim SI, Oh YM, Kang M, Lee S, Hwang S, Lee H, Lee T, Park S, Lee JE, Jeong GR, Lee DH, Youn H, Choi EY, Son WC, Chung SJ, Chung J, Choi K. Park HB, et al. Nat Commun. 2024 Nov 18;15(1):9917. doi: 10.1038/s41467-024-53996-7. Nat Commun. 2024. PMID: 39557825 Free PMC article. - CD40L-Activated DC Promotes Th17 Differentiation and Inhibits Th2 Differentiation in Sepsis-Induced Lung Injury via cGAS-STING Signaling.
Yu W, Yang M, Lv B, Yu Y, Zhu W. Yu W, et al. Biochem Genet. 2024 May 27. doi: 10.1007/s10528-024-10835-0. Online ahead of print. Biochem Genet. 2024. PMID: 38802692 - Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, Racine T, Kang CY, Gaillet B, Garnier A, Gilbert R, Kamen A, Yao XJ, Fowke KR, Arts E, Kobinger G. Berger A, et al. Vaccines (Basel). 2024 Mar 29;12(4):369. doi: 10.3390/vaccines12040369. Vaccines (Basel). 2024. PMID: 38675751 Free PMC article. - Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.
Akinsipe T, Mohamedelhassan R, Akinpelu A, Pondugula SR, Mistriotis P, Avila LA, Suryawanshi A. Akinsipe T, et al. Front Immunol. 2024 Mar 12;15:1302587. doi: 10.3389/fimmu.2024.1302587. eCollection 2024. Front Immunol. 2024. PMID: 38533507 Free PMC article. Review. - Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas.
Su C, Kim SK, Wang CX, Kirsch DG, Monjazeb AM. Su C, et al. Semin Radiat Oncol. 2024 Apr;34(2):243-257. doi: 10.1016/j.semradonc.2024.01.001. Semin Radiat Oncol. 2024. PMID: 38508788 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials